Clinical Trial Update: Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial NAVIGATION is evaluating nivolumab in combination with lenvatinib for anaplastic thyroid carcinoma; the study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)
• OPDIVO (nivolumab)

Snippet

Sponsor: National Cancer Center Hospital East | Conditions: Anaplastic Thyroid Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING